Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
ACTIVE_NOT_RECRUITING
NCT03129555
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
5,000
Enrollment(s)
26
Study location(s)
INTERVENTIONAL (PHASE4)
Deep Vein Thrombosis
Pulmonary Embolism
RECRUITING
NCT06957366
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
920
Enrollment(s)
14
Study location(s)
INTERVENTIONAL (NA)
Atrial Fibrillation (AF)
VTE
TERMINATED
NCT06231693
Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
2
Enrollment(s)
2
Study location(s)
OBSERVATIONAL (None)
Breast Cancer
ACTIVE_NOT_RECRUITING
NCT03273413
Statin Therapy in Patients With Early Stage ADPKD
150
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
ADPKD
Autosomal Dominant Polycystic Kidney
COMPLETED
NCT01717586
Pravastatin for Prevention of Preeclampsia
48
Enrollment(s)
3
Study location(s)
INTERVENTIONAL (PHASE1)
Preeclampsia
RECRUITING
NCT06837792
Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer
141
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Hormone Receptor(HR)-Positive, Low HER2 Advanced Breast Cancer Patients (HER2 IHC 1+ or 2+ & ISH Negative)
RECRUITING
NCT06947707
Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
1,486
Enrollment(s)
1
Study location(s)
OBSERVATIONAL (None)
Cerebral Venous Thrombosis
Anticoagulants and Thrombotic Disorders
Anticoagulation Treatment
Anticoagulant Therapy
Anticoagulant Drugs
NOACs
Anticoagulant Prophylaxis/Therapy
Anticoagulation With NOAC
Anticoagulation With Direct Oral Anticoagulants
COMPLETED
NCT05122455
Effects of Edoxaban on Platelet Aggregation
61
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2|||PHASE3)
SCAD
AMI
26
27
28
29
30